Asahi Kasei Revamps Medical Business, Welcomes New Investors

Asahi Kasei (JP:3407) has released an update.

Asahi Kasei Corp. is restructuring its medical business by establishing Asahi Kasei Life Science Corp. to handle its bioprocess operations, while its subsidiary Asahi Kasei Medical will receive investment from IA Holdings Co., Ltd. through Integral Corporation. The deal will see Asahi Kasei initially transfer 80% of shares in Asahi Kasei Medical to the investing company, with plans to transfer the remaining 20% in the future, aiming to bolster growth and competitiveness in medical devices.

For further insights into JP:3407 stock, check out TipRanks’ Stock Analysis page.